Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALOX5 | P09917 | 2/20 | 0.90 |
| ▸ | PTGES | O14684 | 1/20 | 0.90 |
| ▸ | DYRK1A | Q13627 | 1/20 | 0.73 |
| ▸ | DYRK1B | Q9Y463 | 1/20 | 0.73 |
| ▸ | AKT1 | P31749 | 1/20 | 0.59 |
| ▸ | BCHE | P06276 | 2/20 | 0.59 |
| ▸ | ACHE | P22303 | 2/20 | 0.59 |
| ▸ | PTPN1 | P18031 | 1/20 | 0.57 |
| ▸ | HSD17B2 | P37059 | 1/20 | 0.56 |
| ▸ | TAS2R31 | P59538 | 1/20 | 0.56 |
| ▸ | MEN1 | O00255 | 1/20 | 0.56 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.56 |
| ▸ | CYP1A1 | P04798 | 1/20 | 0.56 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.56 |
| ▸ | POLB | P06746 | 1/20 | 0.56 |
| ▸ | MAPT | P10636 | 1/20 | 0.56 |
| ▸ | ABCC1 | P33527 | 1/20 | 0.56 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.56 |
| ▸ | CYP1B1 | Q16678 | 1/20 | 0.56 |
| ▸ | ABCG2 | Q9UNQ0 | 2/20 | 0.52 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29357680 | 0.95 | ALOX5 (1.00) | ALOX5PTGESDYRK1ADYRK1BAKT1 | |
| SCHEMBL29928945 | 0.95 | ALOX5 (1.00) | ALOX5PTGESDYRK1ADYRK1BAKT1 | |
| SCHEMBL12954625 | 0.95 | ALOX5 (1.00) | ALOX5PTGESDYRK1ADYRK1BAKT1 | |
| SCHEMBL20045161 | 0.89 | ALOX5 (0.90) | ALOX5PTGESDYRK1ADYRK1BAKT1 | |
| SCHEMBL29359086 | 0.86 | PTGES (0.84) | ALOX5PTGESDYRK1ADYRK1BAKT1 | |
| SCHEMBL16769856 | 0.86 | PTGES (0.84) | ALOX5PTGESDYRK1ADYRK1BAKT1 | |
| SCHEMBL20045165 | 0.85 | DYRK1A (1.00) | ALOX5PTGESDYRK1ADYRK1BAKT1 | |
| SCHEMBL26621012 | 0.83 | ALOX5 (0.79) | ALOX5PTGESDYRK1ADYRK1BAKT1 | |
| SCHEMBL21901981 | 0.82 | PTGES (0.74) | ALOX5PTGESDYRK1ADYRK1BAKT1 | |
| SCHEMBL3336171 | 0.81 | ALOX5 (0.77) | ALOX5PTGESDYRK1ADYRK1BAKT1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20180098961-A1 | THERAPEUTIC AGENTS CONTAINING CANNABIS FLAVONOID DERIVATIVES TARGETING KINASES, SIRTUINS AND ONCOGENIC AGENTS FOR THE TREATMENT OF CANCERS | FLAVOCURE BIOTECH, INC. | 2018-04-12 | — | — | US | disclosed |
| US-20180098961-A1 | THERAPEUTIC AGENTS CONTAINING CANNABIS FLAVONOID DERIVATIVES TARGETING KINASES, SIRTUINS AND ONCOGENIC AGENTS FOR THE TREATMENT OF CANCERS | FLAVOCURE BIOTECH, INC. | 2018-04-12 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20180098961-A1 | THERAPEUTIC AGENTS CONTAINING CANNABIS FLAVONOID DERIVATIVES TARGETING KINASES, SIRTUINS AND ONCOGENIC AGENTS FOR THE TREATMENT OF CANCERS | BRDT, BRD4, CKS2 | ALOX5 3411/4885PTGES 2440/4885DYRK1A 2472/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.